Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2021-08-13 00:00:00 ET · period of report 2021-08-11 · accession 0001237899-21-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-08-13 | 2021-08-11+ | REGN | SING GEORGE L | Dir | S - Sale | $617.71 | -3,500 | 44.6K | -7% | -$2.16M |
| I | 2021-08-13 | 2021-08-11 | REGN | SING GEORGE L | Dir | S - Sale | $620.00 | -300 | 3,050 | -9% | -$186.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-11 | S | D | 1,000 | $620.00 | 47,063 | D by Trust for Son | — | — | |
| 2 | Common | Common Stock | 2021-08-11 | S | D | 300 | $620.00 | 3,050 | I | — | — | |
| 3 | Common | Common Stock | 2021-08-11 | S | D | 1,000 | $621.00 | 46,063 | D | — | — | |
| 4 | Common | Common Stock | 2021-08-12 | S | D | 1,000 | $611.00 | 45,063 | D | — | — | |
| 5 | Common | Common Stock | 2021-08-13 | S | D | 500 | $620.00 | 44,563 | D | — | — |